Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy

Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has become the main means for the clinical treatment of unresectable HCC. Among these, TACE is used throughout the stage Ib to IIIb of HCC treatment. In recent years, immunotherapy led by immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jian, Ni, Hongbo, Wang, Fan, Xu, Ke, Niu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562181/
https://www.ncbi.nlm.nih.gov/pubmed/34805958
http://dx.doi.org/10.1016/j.jimed.2021.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562181/
https://www.ncbi.nlm.nih.gov/pubmed/34805958
http://dx.doi.org/10.1016/j.jimed.2021.05.002

Ejemplares similares